ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

KORU Medical Systems Appoints Brian Case As Chief Technology Officer

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced the appointment of Brian Case, a veteran medical technology R&D leader with over 20 years of experience, as the Company’s new Chief Technology Officer. Mr. Case will lead product development and innovation as the Company defines and executes a technology strategy to support a global drug delivery portfolio.

With his proven track record of value creation through R&D technology development, deployment of product development strategy, and merger and acquisition experience, we are confident Brian will be a catalyst to the KORU team,” said Linda Tharby, President and CEO. “Brian is a great fit, with his value system, large and small company background, experiences and passion for the patient. He will be instrumental as we continue to define and execute KORU Medical’s product and technology strategy. His experience with global product and process development from the definition of customer needs to global market commercialization will pave the way for the Company as we strengthen our technology roadmap to serve more patients, partners, and customers.”

Brian joins the KORU Medical Systems team with over 20 years of research and development experience. Most recently, he spent over 16 years at Fresenius Kabi, a global healthcare company specializing in lifesaving medicines and technologies, as Vice President, Research and Development. Mr. Case provided business and technical leadership for the Transfusion and Cell Technologies division to drive long-term product vitality and competitive advantage of the business and promote entry into new business areas. Prior to Fresenius Kabi, Mr. Case spent six years at Cook Medical, a medical device company, as R&D Program Manager, Advanced Research. While there, he managed a cross-functional team that developed and assessed new technologies to create a product portfolio to service the peripheral disease market. Mr. Case received his Master of Science in Engineering Management from the Rose-Hulman Institute of Technology, and his Bachelor of Science in Engineering Mechanics, from the University of Illinois. In addition, Mr. Case is an inventor on over 100 patents, a Licensed Professional Mechanical Engineer, and a Certified Project Management Professional.

“I’m honored to be joining KORU at such a transformational stage in the company’s journey,” said Brian Case. “This is such an exciting opportunity to help drive innovation and develop best-in-class infusion solutions to better serve our patient community. There is so much potential, and I can’t wait to get started.”

About KORU Medical Systems

KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing and HIgH-Flo Subcutaneous Safety Needle Sets. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  258.88
-4.16 (-1.58%)
AAPL  272.36
+2.19 (0.81%)
AMD  349.00
+11.89 (3.53%)
BAC  53.44
+0.55 (1.05%)
GOOG  374.63
+27.32 (7.87%)
META  609.00
-60.12 (-8.98%)
MSFT  402.80
-21.66 (-5.10%)
NVDA  200.72
-8.53 (-4.08%)
ORCL  162.63
-1.20 (-0.73%)
TSLA  379.59
+6.79 (1.82%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.